Fig. 2From: Antitumoral effects of cyclin-dependent kinases inhibitors CR8 and MR4 on chronic myeloid leukemia cell linesAnalysis of cell cycle in KCL22 cell line. a Cells were treated or not by 1 μM Roscovitine or R-CR8 for increasing times and distribution of cells among the different phases of cell cycle was assessed by DNA content staining with PI (FL2-log). b Western-blotting analysis of CDK1/cdc2, PSTAIR-containing CDKs and CDK7 after 24 h treatment of KCL22 cells. Actin was used as a control of sample loading. No T not treated, Imat Imatinib, Rosc RoscovitineBack to article page